Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease

Figure 4 Microbial control strategies for treating non-alcoholic fatty liver disease. The management of non-alcoholic fatty liver disease (NAFLD) through microbial control includes the use of antibiotics, prebiotics, probiotics, synbiotics, and fecal microbiota suppression to regulate oral and gut microbiomes, maintain microbial balance, and protect mucosal barriers, ultimately reducing the bacterial influence on NAFLD.